XBIOTECH INC's ticker is and the CUSIP is 98400H902. A total of 1 filers reported holding XBIOTECH INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $11,286 | +61.2% | 1,900 | +58.3% | 0.00% | – |
| Q2 2022 | $7,000 | -36.4% | 1,200 | -7.7% | 0.00% | – |
| Q1 2022 | $11,000 | +175.0% | 1,300 | +225.0% | 0.00% | – |
| Q4 2021 | $4,000 | 0.0% | 400 | +33.3% | 0.00% | – |
| Q3 2021 | $4,000 | -97.2% | 300 | -96.5% | 0.00% | – |
| Q2 2021 | $141,000 | -18.5% | 8,500 | -15.8% | 0.00% | – |
| Q1 2021 | $173,000 | +94.4% | 10,100 | +77.2% | 0.00% | – |
| Q4 2020 | $89,000 | +6.0% | 5,700 | +29.5% | 0.00% | – |
| Q3 2020 | $84,000 | -72.6% | 4,400 | -80.4% | 0.00% | -100.0% |
| Q2 2020 | $307,000 | +113.2% | 22,400 | +64.7% | 0.00% | 0.0% |
| Q1 2020 | $144,000 | +87.0% | 13,600 | +231.7% | 0.00% | 0.0% |
| Q4 2019 | $77,000 | +413.3% | 4,100 | +105.0% | 0.00% | – |
| Q2 2019 | $15,000 | -34.8% | 2,000 | -4.8% | 0.00% | – |
| Q1 2019 | $23,000 | +109.1% | 2,100 | 0.0% | 0.00% | – |
| Q4 2018 | $11,000 | -89.4% | 2,100 | -93.6% | 0.00% | -100.0% |
| Q3 2018 | $104,000 | +1633.3% | 32,700 | +2235.7% | 0.00% | – |
| Q2 2018 | $6,000 | -90.5% | 1,400 | -88.0% | 0.00% | -100.0% |
| Q1 2018 | $63,000 | -6.0% | 11,700 | -31.2% | 0.00% | – |
| Q4 2017 | $67,000 | +34.0% | 17,000 | +49.1% | 0.00% | – |
| Q3 2017 | $50,000 | -71.6% | 11,400 | -69.6% | 0.00% | -100.0% |
| Q2 2017 | $176,000 | -84.7% | 37,500 | -46.3% | 0.00% | -84.6% |
| Q1 2017 | $1,151,000 | +371.7% | 69,800 | +189.6% | 0.01% | +550.0% |
| Q4 2016 | $244,000 | +2611.1% | 24,100 | +3342.9% | 0.00% | – |
| Q3 2016 | $9,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |